Importance Patients with concomitant peripheral arterial disease (PAD) experience worse
cardiovascular outcomes after percutaneous coronary intervention (PCI). Objective To …

Introduction The decision to shorten the duration of DAPT following PCI in patients with ACS
remains controversial because of the concern for increased ischemic events. Methods We …

Objective To estimate the incidence and HRs for bleeding for different dual antiplatelet
therapies (DAPT) in a real-world population with acute coronary syndrome (ACS) …

Despite a large volume of evidence supporting the use of dual antiplatelet therapy in
patients with acute coronary syndrome, there remains major uncertainty regarding the …

Introduction Bleeding is an independent risk factor of mortality in patients with acute
coronary syndromes (ACS). BleeMACS project focuses on long-term bleeding events after …

Aims Data on the clinical impact of gender in “real‐life” patients with acute coronary
syndrome (ACS) undergoing percutaneous coronary intervention (PCI), receiving …

Importance Women experience worse ischemic and bleeding outcomes after percutaneous
coronary intervention (PCI). Objectives To assess the association of sex with patient …

Background Elderly patients with acute coronary syndrome (ACS) are at high risk for
ischemic and bleeding events. This study aimed to evaluate the clinical effectiveness and …

This review is a summary of the European Society of Cardiology (ESC) guidelines focused
on dual antiplatelet therapy in patients after percutaneous coronary interventions (PCI) …

Objective To describe international patterns of dual antiplatelet therapy (DAPT) duration
after acute coronary syndrome (ACS), and explore its determinants and correlation with …